9月24日，超研股份涨1.52%，成交额4873.31万元。两融数据显示，当日超研股份获融资买入额293.90 万元，融资偿还1016.28万元，融资净买入-722.38万元。截至9月24日，超研股份融资融券余额合计1.02 亿元。 融资方面，超研股份当日融资买入293.90万元。当前融资余额1.02亿元，占流通市值的7.03%。 资料显示，汕头市超声仪器研究所股份有限公司位于广东省汕头市金砂路77号，成立日期1982年11月15 日，上市日期2025年1月22日，公司主营业务涉及专业从事医学影像设备、工业无损检测设备的研发、 生产和销售的国家级重点高新技术企业。主营业务收入构成为：医用超声71.16%，工业超声17.30%， 配附件5.72%，X射线4.56%，其他(补充)1.26%。 截至6月30日，超研股份股东户数2.23万，较上期减少16.65%；人均流通股2456股，较上期增加 19.98%。2025年1月-6月，超研股份实现营业收入1.84亿元，同比增长15.00%；归母净利润6844.55万 元，同比增长18.50%。 融券方面，超研股份9月24日融券偿还0.00股，融券卖出0.00股，按当日收 ...

摘要 ： 多浦乐2025上半年营收增长56.19%，净利润增长12.15%，研发投入占比28.02%，积极开拓新市场并深耕核心技 术。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，广州多浦乐电子科技股份有限公司（以下简称"多浦乐"）发布了2025年半年度报告，交出了一份亮眼的"期中 成绩单"。报告显示， 公司实现营业收入7998.51万元，较上年同期大幅增长56.19%；实现归属于上市公司股东的 净利润1903.76万元，同比增长12.15% 。 保持技术研发优势： 公司作为核心单位参与多项国家级研发项目，先后承担了"相控阵超声检测系统"及"超声成像工 业无损检测仪"等国家研发项目，面向科研院所、高校以及航天航空、 核电等行业的复杂检测需求，开展高性能超声 相控阵检测设备及模块研制，以期实现更高效、更精准的检测效果。 多浦乐表示，未来将继续依托技术积累和市场拓展能力，推动无损检测设备在更多高端工业领域的创新应用，提升公司 在全球市场的竞争力。 点击文末"阅读原文"查看详情 多浦乐是一家专业从事无损检测设备研发、生产和销售的高新技术 ...

Major Events - The actual controller, chairman, and CEO of Juran Smart Home, Wang Linpeng, passed away on July 27, 2025. He held a total of 43.93% of the company's shares. The board has appointed Wang Ning as the acting chairman and CEO [3] - Shennong Group has decided to terminate its plan for a specific stock issuance for 2024 due to changes in market conditions and will withdraw its application [5] - Xizhuang Co. plans to establish a joint venture to engage in sustainable aviation fuel-related business with a registered capital of 5 million yuan, where Xizhuang will contribute 1.1 million yuan [6] - Shandong Gold's subsidiary, Shanjin International, intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [7] - Luopusi Co. plans to acquire a 38.38% stake in Wuhan Senfurui Technology Co. for 8.82 million yuan [8] - Hengxin Life plans to invest no more than 505 million yuan to build a biodegradable product production base in Hefei, Anhui Province [9] - Hetai Machinery announced it has not participated in the Yaxi project construction, which is still in the early stages [10] - Kaishan Co. plans to acquire a 5% stake in SMGP for 3 million USD, resulting in full ownership of the company [11] - Ruian New Materials intends to terminate its raw material project due to uncertainties in the second phase of construction [12] - Zhonghua Equipment plans to purchase 100% equity of Yiyang Rubber Machine and Beihua Machine, with stock resuming trading on July 29, 2025 [13] - Huizhou Intelligent announced that a board member has resigned due to being identified as a dishonest executor [14] - Xuefeng Technology plans to acquire a 51% stake in Shengshi Putian for 154 million yuan [15][16] - Top Cloud Agriculture intends to establish a wholly-owned subsidiary focused on artificial intelligence technology with an investment of 20 million yuan [17] - Shiming Technology's actual controller is under detention, but it does not affect the company [18] - Dahua Intelligent is under investigation by the CSRC for suspected information disclosure violations [19] - Dalian Shengya plans to change its controlling shareholder and will resume trading on July 29, 2025 [20] - Fashilong has signed a share transfer agreement and will resume trading on July 29, 2025 [21] - Guangku Technology plans to acquire control of Anjie Xun, with trading suspended from July 29, 2025 [22] - Tianyi Co. has been selected as a candidate for a procurement project by China Mobile [23] - Zhongtung High-tech's subsidiary plans to implement a 1.4 billion drill bit intelligent manufacturing project with an investment of 178 million yuan [24] Performance Overview - WuXi AppTec reported a net profit of 8.561 billion yuan for the first half of 2025, a year-on-year increase of 101.92% [25] - Sujiao Science and Technology's net profit decreased by 39.54% year-on-year, with a revenue of 1.776 billion yuan [26] - Aide Biology achieved a net profit of 189 million yuan, up 31.41% year-on-year [27] - Huicheng Environmental's net profit dropped by 85.63% year-on-year, with a revenue of 564 million yuan [28] - Haida Group reported a net profit of 2.639 billion yuan, a year-on-year increase of 24.16% [30] Major Contracts - Weiye Co. won a construction project worth approximately 522 million yuan [31] - Fosun Pharma's subsidiary signed a licensing agreement for a drug targeting Alzheimer's disease [32] - Huafeng Aluminum plans to sign a raw material purchase contract with Yulin New Materials, with an estimated total amount exceeding 7.2 billion yuan [33] Shareholding Changes - Suneng Co. plans to reduce its stake by up to 1% [34] - Shengyang Technology's shareholder plans to reduce its stake by up to 1% [35] - Jingquan Hua's shareholder plans to reduce its stake by up to 1% [36] - Tigermed plans to reduce its stake by up to 3% [38] Financing Activities - Huhua Co. plans to raise no more than 586 million yuan through a private placement for various projects [39]

Core Viewpoint - The recent shareholding changes and performance decline of Duopule (301528.SZ) have raised investor concerns, particularly regarding the confidence of major shareholders in the company's future prospects [2][3][4]. Shareholder Changes - Major shareholder Cai Shuping plans to reduce his holdings by up to 1.238 million shares, representing 2% of the total share capital, within three months starting from June 4, 2025 [3][4]. - This follows a previous reduction completed in January 2025, where Cai sold 537,200 shares at an average price of 44.59 yuan per share, raising approximately 23.95 million yuan [4]. - Another significant shareholder, Xiamen Rongyu, along with its action-in-concert party Suzhou Rongyu, plans to collectively reduce their holdings by up to 3 million shares, or 4.85% of the total share capital, from May 20 to August 17, 2025 [5]. Financial Performance - Duopule's revenue for 2023 was 199 million yuan, a year-on-year decline of 1.41%, with net profit dropping by 8.88% to 77.81 million yuan [7]. - In 2024, revenue further decreased to 162 million yuan, down 18.70%, and net profit fell by 33.68% to 51.60 million yuan [7]. - The company reported a significant increase in revenue in Q1 2025, achieving 38.49 million yuan, a year-on-year growth of 125.44%, but the gross margin decreased by 6.25% [8]. Industry Context - Duopule operates in a technology-intensive sector focused on non-destructive testing equipment, which requires high levels of R&D investment to maintain competitiveness [6]. - The company invested 38.40 million yuan in R&D in 2024, a 13.94% increase from the previous year, accounting for 23.70% of its revenue [6]. - The domestic non-destructive testing equipment industry is still in a growth phase, with a domestic market penetration rate of 52% as of 2023, but high-end products are predominantly supplied by foreign companies [6][8]. Strategic Developments - Duopule is actively expanding into the medical sector, having invested in companies related to medical ultrasound technology, although these initiatives are currently in the investment phase and have not yet contributed significantly to revenue [8][9].

导读： 多浦乐2024年实现营业收入1.62亿元，同比下降18.70%；归属于上市公司股东的净利润为0.52亿元，同比下降33.68%。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，广州多浦乐电子科技股份有限公司（简称：多浦乐）发布了2 0 2 4年度报告。报告显示，多浦乐全年实现营业收入1 . 6 2亿元，同比下降 1 8 . 7 0%；归属于上市公司股东的净利润为0 . 5 2亿元，同比下降3 3 . 6 8%。尽管业绩承压，多浦乐在技术创新和市场拓展方面持续发力，未来战 略聚焦医疗领域和自动化检测设备，力争实现业务多元化发展。 2 0 2 4年，多浦乐的收入主要来源于工业无损检测设备、超声换能器及配套零部件的销售。其中，工业无损检测设备实现营业收入7 , 0 4 5 . 1 9万 元，同比下降2 7 . 1 8%；超声换能器收入5 , 6 7 3 . 9 9万元，同比下降11 . 3 7%；配套零部件收入3 , 2 1 5 . 1 7万元，同比下降8 . 0 8%。 公司表示，营收下滑的主要原因是国内经济增速放缓导致 ...